[go: up one dir, main page]

AU2001275694A1 - Use of oligosaccharides to stimulate beta-endorphin production - Google Patents

Use of oligosaccharides to stimulate beta-endorphin production

Info

Publication number
AU2001275694A1
AU2001275694A1 AU2001275694A AU7569401A AU2001275694A1 AU 2001275694 A1 AU2001275694 A1 AU 2001275694A1 AU 2001275694 A AU2001275694 A AU 2001275694A AU 7569401 A AU7569401 A AU 7569401A AU 2001275694 A1 AU2001275694 A1 AU 2001275694A1
Authority
AU
Australia
Prior art keywords
oligosaccharide
oligosaccharides
endorphin production
skin
stimulate beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275694A
Inventor
Frederic Bonte
Marc Dumas
Stephane Lhermite
Alex Saunois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Publication of AU2001275694A1 publication Critical patent/AU2001275694A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Use of at least one oligosaccharide comprising 2-6 sugars and containing at least 2 galactose groups, preferably side groups, and especially at the end of the chain, or such oligosaccharide- containing plant extract, as cosmetic or dermatological agent stimulating beta-endorphin production in skin. An independent claim is also included for the process of cosmetic treatment comprising application of at least one oligosaccharide as claimed or such oligosaccharide- containing plant extract, optionally in cosmetically acceptable excipient, onto relevant area of skin.
AU2001275694A 2000-07-07 2001-07-05 Use of oligosaccharides to stimulate beta-endorphin production Abandoned AU2001275694A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0008879A FR2811228B1 (en) 2000-07-07 2000-07-07 USE OF OLIGOSACCHARIDES OR PLANT EXTRACTS CONTAINING AS A COSMETIC OR DERMATOLOGICAL AGENT IN PARTICULAR FOR STIMULATING THE PRODUCTION OF BETA-ENDORPHIN IN THE SKIN
FR0008879 2000-07-07
PCT/FR2001/002154 WO2002003945A1 (en) 2000-07-07 2001-07-05 Use of oligosaccharides to stimulate beta-endorphin production

Publications (1)

Publication Number Publication Date
AU2001275694A1 true AU2001275694A1 (en) 2002-01-21

Family

ID=8852235

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275694A Abandoned AU2001275694A1 (en) 2000-07-07 2001-07-05 Use of oligosaccharides to stimulate beta-endorphin production

Country Status (10)

Country Link
US (2) US20030157200A1 (en)
EP (2) EP1911494A3 (en)
JP (1) JP2004502713A (en)
KR (1) KR100793912B1 (en)
CN (2) CN101444470B (en)
AT (1) ATE383893T1 (en)
AU (1) AU2001275694A1 (en)
DE (1) DE60124715T2 (en)
FR (1) FR2811228B1 (en)
WO (1) WO2002003945A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4178829B2 (en) * 2002-05-02 2008-11-12 株式会社Ｊ−オイルミルズ Antiallergic composition
WO2003101464A1 (en) * 2002-05-31 2003-12-11 Amano Enzyme Inc. Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
EP1631594A1 (en) * 2003-02-04 2006-03-08 Solabia (SA) Novel agent for stimulating the release of beta-endorphins, cosmetic and/or dermatological compositions containing same and uses thereof
FR2857873B1 (en) * 2003-07-21 2006-02-24 Courtage Et De Diffusion Codif METHOD AND COSMETIC PRODUCT FOR LIMITING THE GROWTH OF ADIPOSE TISSUES
FR2857874A1 (en) * 2003-07-21 2005-01-28 Courtage Et De Diffusion Codif Use of beta-endorphin, or agents that stimulate its production, for pharmaceutical or cosmetic modification of keratinocyte differentiation
EP1529532A1 (en) * 2003-11-07 2005-05-11 Kabushiki Kaisha Honen Corporation Antiallergic composition comprising stachyose
JP2005179224A (en) * 2003-12-18 2005-07-07 Noevir Co Ltd Skin care preparation for external use
FR2868307B1 (en) * 2004-04-01 2008-03-14 Courtage Et De Diffusion Codif USE OF BETA-ENDORPHINE FOR THE TREATMENT OF WRINKLES
FR2868703B1 (en) * 2004-04-08 2008-06-13 Expanscience Sa Lab TOTAL LUPINE EXTRACT CONSISTING OF LUPINE SUGAR EXTRACT AND LUPINE PEPTIDE EXTRACT, PROCESS FOR OBTAINING AND USING SAME
JP5207664B2 (en) * 2007-06-04 2013-06-12 株式会社シャネル化粧品技術開発研究所 Cosmetics
KR101098581B1 (en) * 2009-01-09 2011-12-26 서울대학교산학협력단 Composition for Improving Inflammatory Disorder Using ABH Antigen
KR102275055B1 (en) * 2014-04-30 2021-07-08 (주)아모레퍼시픽 Composition comprising scutellaria alpina extract
JP2019510036A (en) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド A detergent composition comprising probiotic / prebiotic active ingredients
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
EP3544575A1 (en) 2016-11-23 2019-10-02 GOJO Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US10383809B2 (en) * 2017-01-13 2019-08-20 Galactic Beauty, LLC Skin treatment compositions, masks and related methods
JP7274720B2 (en) * 2018-09-26 2023-05-17 株式会社クラブコスメチックス Estrogen receptor expression promoter and cell proliferation promoter
KR102282246B1 (en) * 2020-10-27 2021-07-27 쿼럼바이오 주식회사 Composition for preventing, alleviating, or treating atopic dermatitis
CN113712869B (en) * 2021-09-24 2023-08-18 杭州配方师科技有限公司 A kind of essence containing gray edamame seed and roselle flower compound extract and its preparation method
CN113662982A (en) * 2021-09-24 2021-11-19 杭州配方师科技有限公司 Extract of grifola frondosa seeds and roselle flowers, extraction method and application
FR3143372A1 (en) 2022-12-20 2024-06-21 C F E B Sisley NEUROCOSMETIC COMPOSITION TO PREVENT THE EFFECTS OF STRESS
CN117357421A (en) * 2023-10-25 2024-01-09 华熙生物科技股份有限公司 Skin external composition containing ergothioneine and dipeptide-1 or derivatives thereof and uses thereof
CN119074607B (en) * 2024-08-29 2025-08-12 诺德溯源(广州)生物科技有限公司 Licorice plant sunscreen composition suitable for sensitive skin and preparation method thereof
CN119104707A (en) * 2024-09-20 2024-12-10 广东迪美新材料科技有限公司 An in vitro method for evaluating the neurocosmetic efficacy of cosmetic raw materials and finished products
CN119235714A (en) * 2024-09-26 2025-01-03 诺德溯源(广州)生物科技有限公司 An anti-inflammatory and acne-removing composition for conditioning acne-sensitive skin and its application

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59176203A (en) * 1983-03-28 1984-10-05 Kanebo Ltd Skin cosmetic
LU84979A1 (en) * 1983-08-30 1985-04-24 Oreal COSMETIC OR PHARMACEUTICAL COMPOSITION IN AQUEOUS OR ANHYDROUS FORM WHOSE FATTY PHASE CONTAINS OLIGOMER POLYETHER AND NEW OLIGOMER POLYETHERS
ES2191664T5 (en) * 1992-07-13 2008-02-16 Shiseido Company, Ltd. COMPOSITION FOR DERMATOLOGICAL PREPARATION.
FR2708198B1 (en) * 1993-07-28 1995-10-20 Dior Christian Parfums Cosmetic or pharmaceutical composition, in particular dermatological composition containing an extract of Tephrosia, in particular Tephrosia purpurea.
FR2709061B1 (en) * 1993-08-17 1996-07-19 Ladislas Robert Use of oligosaccharides in the prevention and treatment of tissue aging.
JP3963972B2 (en) * 1995-11-17 2007-08-22 三省製薬株式会社 Topical skin preparation
FR2762783B1 (en) * 1997-05-02 2002-09-13 Roc Sa USE OF OLIGOSACCHARIDES FOR THE TREATMENT OF CONNECTIVE TISSUE AND METHOD OF COSMETIC TREATMENT USING SUCH OLIGOSACCHARIDES
US6030620A (en) * 1997-07-25 2000-02-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing an organic extract of chick pea
JP2003514001A (en) * 1999-11-16 2003-04-15 ユニリーバー・ナームローゼ・ベンノートシヤープ Beauty composition comprising chickpea extract and retinoid

Also Published As

Publication number Publication date
JP2004502713A (en) 2004-01-29
CN101444470B (en) 2011-10-05
US20030157200A1 (en) 2003-08-21
ATE383893T1 (en) 2008-02-15
EP1299081A1 (en) 2003-04-09
EP1911494A3 (en) 2008-07-02
FR2811228B1 (en) 2002-10-25
CN101444470A (en) 2009-06-03
EP1911494A2 (en) 2008-04-16
FR2811228A1 (en) 2002-01-11
KR20030062238A (en) 2003-07-23
KR100793912B1 (en) 2008-01-15
US20080020073A1 (en) 2008-01-24
CN1440276A (en) 2003-09-03
DE60124715D1 (en) 2007-01-04
WO2002003945A1 (en) 2002-01-17
DE60124715T2 (en) 2008-11-06
EP1299081B1 (en) 2008-01-16
EP1299081B9 (en) 2009-03-11

Similar Documents

Publication Publication Date Title
AU2001275694A1 (en) Use of oligosaccharides to stimulate beta-endorphin production
AU2001253038A1 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
AUPQ878600A0 (en) Compositions and methods for the treatment of intact skin
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
AU6649996A (en) Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
WO1997001343A3 (en) Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin
WO2001066076A3 (en) Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions
SI1496917T1 (en) Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
AU2001240940A1 (en) Cosmetic and dermatological composition for psoriatic skin, scalp treatment and care
AU2001286562A1 (en) Use of agaricus blazei murill to prevent or treat skin and other disorders
RU95103892A (en) COMPOSITION FOR TOPIC APPLICATION FOR HAIR GROWTH STIMULATION AND/OR THEIR FALLING OUT RETARDATION, METHOD OF COSMETIC HAIR TREATMENT, USE OF α-PYRONE DERIVATIVE FOR COMPOSITION PREPARING
ATE77230T1 (en) MELATONIN-CONTAINING AGENTS AND THEIR USES.
ATE260639T1 (en) TOPICAL PREPARATIONS CONTAINING SIALYL SUGAR AND THEIR DERIVATIVES
PL369453A1 (en) Methods for improving the aesthetic appearance of skin
PL348781A1 (en) Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
BG101126A (en) The use of muramylpeptide compounds
AU6241096A (en) A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders
CA2335495A1 (en) Methods of exfoliation using n-acetyl glucosamine
MXPA03011622A (en) Use of glycoprotein for the treatment and re-epithelialisation of wounds.
WO2003092645A3 (en) Cosmetic composition comprising monosaccharides or polysaccharides____________________________________
WO2001039738A3 (en) Use of flavones and/or isoflavones from plant extracts
WO2004098543A3 (en) Use of oligogalacturonide-type oligosaccharides in cosmetic, food or dermatological compositions in order to stimulate epidermal cell differentiation
AU2509801A (en) Method for the cosmetic treatment of human skin
BG105924A (en) Composition for the treatment of psoriasis
WO2002024156A3 (en) Topical skin-treatment agent containing arginase